CHRNA7 and Alzheimer disease: NBP14, the cyclized version of T14 that blocks its linear counterpart by displacing it from the α7 nAChR, has shown therapeutical potential in the attenuation of cognitive impairment and amyloid production in 5xFAD mouse model of AD, further corroborating the implication of T14 in the pathogenesis of AD [13].